Jefferies Group LLC - ARRAY BIOPHARMA INC ownership

ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 125 filers reported holding ARRAY BIOPHARMA INC in Q2 2013. The put-call ratio across all filers is 1.64 and the average weighting 0.2%.

Quarter-by-quarter ownership
Jefferies Group LLC ownership history of ARRAY BIOPHARMA INC
ValueSharesWeighting
Q2 2019$12,055,000
+6416.2%
260,196
+1697.6%
0.09%
+8700.0%
Q4 2017$185,000
-92.3%
14,475
-95.0%
0.00%
-93.8%
Q2 2017$2,406,000
+11.2%
287,449
+18.8%
0.02%
-5.9%
Q1 2017$2,164,000
+525.4%
242,012
+372.5%
0.02%
+750.0%
Q3 2016$346,000
+686.4%
51,220
+389.0%
0.00%
Q4 2015$44,000
-82.5%
10,475
-79.0%
0.00%
-100.0%
Q4 2013$251,000
-45.0%
50,000
-50.2%
0.00%
-60.0%
Q2 2013$456,000100,3870.01%
Other shareholders
ARRAY BIOPHARMA INC shareholders Q2 2013
NameSharesValueWeighting ↓
Redmile Group, LLC 16,459,128$234,543,0009.43%
APIS CAPITAL ADVISORS, LLC 490,000$6,983,0009.36%
BVF INC/IL 4,744,062$67,603,0008.84%
First Light Asset Management, LLC 2,853,826$40,667,0006.48%
SECTORAL ASSET MANAGEMENT INC 2,165,767$30,862,0004.20%
GREAT POINT PARTNERS LLC 1,850,000$26,363,0003.33%
PACIFIC VIEW ASSET MANAGEMENT, LLC 146,952$2,092,0002.46%
Birchview Capital, LP 168,000$2,394,0002.26%
X-Square Capital, LLC 180,554$2,572,0002.02%
FINANCIAL & INVESTMENT MANAGEMENT GROUP LTD 295,610$4,212,0001.54%
View complete list of ARRAY BIOPHARMA INC shareholders